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Comparative Mammalian Metabolism
of Vinyl Chloride and Vinylidene
Chloride in Relation to Oncogenic
Potential
by David E. Hathway*
Elucidation of the role of vinyl chloride metabolites in the various reaction sequences which comprise
themetabolic pathway, including the interaction ofreactive metabolites with some purine and pyrimidine
residues of target-organ DNA, provides some explanation for the (oncogenic) properties associated with
the original substance. Comparative investigation of the biological fate of vinylidene chloride reveals an
agent of low oncogenic potential which is likely to be damaging only under special circumstances, and
species differences which suggest that the mouse is more susceptible than the rat towards vinylidene
chloride oncogenicity.
The research work with which this communica-
tion is concerned isbased onthe ideathatknowledge
ofthe biology ofthe reactive metabolites ofchemical
carcinogens in the mammal, including the precise
nature of the chemical changes to the DNA of the
nucleus, ought to give an insight into the (oncogenic)
properties of the parent compounds.
In tracer studies, N-acetyl-S-(2-hydroxymethyl)-
cysteine was shown to be a major vinyl chloride
metabolite in rats, but according to the method of
protective esterification that was used so aderivative
either of N-acetyl-S-(2-chloroethyl)cysteine or of
N-acetyl-S-(2-hydroxyethyl)cysteine was isolated
from body fluids (1, 2). Thus, by Fischer-Speier
methylation,N-acetyl-S-(2-chloroethyl)cysteine
was obtained, and with diazomethane, N-acetyl-
S-(2-hydroxyethyl)cysteine. It might be stated
in passing that throughout the investigations de-
scribed, mass spectrometry, involving electron im-
pact (El) and chemical ionization sources and
multiple-ion detection and all combinations ofthese
facilities, was used extensively both for product
identification and analysis and for the purposes of
detection. Treatment of the 0-methyl ester of
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N-acetyl-S-(2-hydroxyethyl)cysteine (a) with the
methanol-HCl reagent gave a mixture of
N-acetyl-S-(2-chloroethyl)cysteine (b), and S-
(2-chloroethyl)cysteine, and conversely, the
0-methyl ester of N-acetyl-S-(2-chloroethyl)-
cysteine (b) was hydrolyzed rapidly by water
to that of N-acetyl-S-(2-hydroxyethyl)cysteine
(a) (2). Hence, the reversible reaction processes
connecting the two substances would seem to be
modulated through the intermediacy of episulf-
onium ion (c) and formation ofthis ion would in fact
be rate-limiting in respect of the hydrolysis of
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December 1977 55N-acetyl-S-(2-chloroethyl)cysteine. Nucleophilic
attack of OH- on the episulfonium ion would be
expected to give olefin (3), and in fact, N-
acetyl-S-vinylcysteine (d) (2) was recovered from
*the urine of vinyl chloride-treated animals
whenever diazomethane esterification was used to
protect S-containing metabolites.
Surprisingly, N-acetyl-S-(2-hydroxyethyl)cy-
steine 0-methyl ester was methylated with neu-
tral methanol, and the 0-methyl esters of N-acetyl-
S-(2-methoxy[14C]ethyl)cysteine plus N-acetyl-
S-['4C]vinyl-cysteine degrade to give the volatile
[14C]S-(2-methoxyethyl) (prop-i or 2-enyl) sulfide.
Although the mechanism offormation was not inves-
tigated, we felt that acetaldehyde, a known dissocia-
tion product of S-vinylcysteine-derived S-vinyl-
cysteine-S-oxide (4) might undergo concerted con-
densation with N-acetyl-S-(2-methoxyethyl)cysteine
leading to elimination of thermodynamically stable
glyoxylate. [There is an analogy for such aconcerted
condensation reaction in the work of Dabritz and
Virtanen (4) on the tear-producing volatile compo-
nents of the onion.]
The half-mustard S-containing metabolites ofvinyl
chloride did notbehave as mutagens in the Ames test
(2).
Thiodiglycollic acid is another majorvinyl chloride
metabolite (1).
In order to determine whether vinyl chloride
yielded chloroethylene oxide in vivo, the biogenesis
of several vinyl chloride metabolites and related
compounds were investigated in rats (2). S-
(2-Hydroxyethyl)cysteine gave 0.5% ofthe authentic
thiodiglycollic acid, and this result was seen to be
highly significant, because of the instability
(v. supra) of the starting material under exceedingly
mild conditions of reaction. The metabolic pathway
concerned [Eq. (1)] appears to include endgroup
oxidation (I), amino-acid transamination (II), and
oxidative decarboxylation (III), and the results of
the animal feeding experiments suggest that
chloroacetaldehyde (g) chloroacetic acid (h), and
S-(2-carboxymethyl)cysteine (i) might lie on a com-
mon pathway connecting vinyl chloride (e) with
thiodiglycollic acid 0). However, other evidence im-
plies thatchloroacetic acid (h) does notbelong to this
metabolic pathway (e-j). Thus, < 0.1% has even
been detected in the body fluids of any of our vinyl
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chloride-treated animals. Eitherthere is ahigh rate of
turn-over or this compound is not a major vinyl
chloride metabolite. The latter possibility seems
more likely, since relatively large amounts are pro-
duced in vinylidene chloride metabolism, and in
those animals, thiodiglycollic acid accounts for an
even greater proportion of the dose than in parallel
experiments with vinyl chloride. A feasible
metabolic pathway for thiodiglycollic acid from
chloroacetic acid and involving cysteine desulfhy-
drase is unacceptable. Experiments with unlabeled
vinyl chloride in rats in which the cysteine-cystine
pools had been labeled adequately with "4C gave
[14C]thiodiglycollic acid, showing that a part of the
C-skeleton must be derived in fact from cysteine. In
rats treated with chloroacetaldehyde, the presence of
thiodiglycollic acid and N-acetyl-S-(2-hydroxy-
ethyl)cysteine, but not of chloroacetic acid, among
the urinary metabolites was established by mass
fragmentometry.
Thus, it is probable that in vivo chloroethylene
Environmental Health Perspectives 56oxide (f) was formed (5) from vinyl chloride (e) and
transformed spontaneously (6) into chloroacetal-
dehyde (g); there is supporting evidence (7-10) for
vinyl chloride epoxidation in vitro. This supposition
is supported by the facts that chloroacetaldehyde
affords both N-acetyl-S-(2-hydroxyethyl)cysteine
and thiodiglycollic acid in vivo and that S-(2-
carboxymethyl) cysteine has been identified by mass
fragmentometry amongst the hydrolytic products of
an hepatic extract prepared from vinyl chloride-
treated animals. Since chloroacetaldehyde and
chloroethylene oxide are mutagenic in the Ames test
(11-13) and in Chinese hamster V79 cells (14), they
may be relevant to vinyl chloride carcinogenicity.
Respective formation of 9,8-D-2'-deoxy ribofur-
anosylimidazo-[2,1-i]purine or 3,8-D-2'-deoxy
ribofuranosyl-2-oxo-2,3-dihydroimidazo-[ 1,2-c]py-
rimidine from deoxy adenosine or deoxy cytidine by
reaction with chloroacetaldehyde (15) or chloro-
ethylene oxide was readily confirmed. Recognition
ofthe nucleoside units of DNA that were modified
by reaction with active vinyl chloride metabolites in
vivo provides opportunity for the construction from
appropriate animal data of the corresponding dose-
response, time-response relationships, in compari-
son with the ones for tumor incidence/occurrence in
those animals. The presence of these two im-
idazonucleoside derivatives has now been estab-
lished by mass fragmentometry (16) in the enzymic
hydrolysate of modified rat-liver DNA, prepared
from rats, which had been exposed chronically to
vinyl chloride (250 ppm in their drinking water)
for 1 year (Fig. 1). A smaller proportion of
the 9,8-D-2'-deoxy ribofuranosylimidazo-
[2,1-i]purine, than would have been expected to
have been formed, was found both in the animal
experiments with vinyl chloride and in model reac-
tions between chloroacetaldehyde and calf thymus
DNA (16). This observation is consistent with
some degree of DNA depurination brought about
by the reaction of vinyl chloride, and in our model
experiments, we have found evidence for the pres-
ence of the detached purine, viz., imidazo-[2,1-i]
purine. Hence, the alkylation that produces
imidazo-derivative formation (with DNA) labilizes
the N9-purine ,B-glycoside linkage, which leads to
depurination. The gap so produced might then be
filled by various bases, resulting in "mispairing"
during DNA replication. These results are very im-
portant, because in general, there is excellent
agreement between the severe damaging effect of
depurination to DNA and mutagenicity (17-19).
Thus, in retrospect, one would suspect vinyl
chloride ofbeing mutagenic/carcinogenic.
On the other hand, vinylidene chloride (k)
metabolism in rats gave thiodiglycollic acid (r) and
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FIGURE 1. Scheme suggesting the model reaction of
chloroacetaldehyde with (calf-thymus) DNA and the bio-
transformation ofhepatocyte DNA by vinyl chloride in i'h'o.
Both reaction processes afford 3,8-D-2'-deoxy ribofur-
anosyl-3,8-oxo-2,3-dihydroimidazo- [1 ,2-c]pyrimidine
(left-hand side) and 9'f3-D-2'-deoxy ribofuranosylimidazo-
[2,1-i]purine (right-hand side).
an N-acetyl-S-cysteinyl-acetyl derivative (p) as
majorurinary metabolites, plus substantial amounts
of chloroacetic acid (1), dithioglycollic acid (t) and
thioglycollic acid (s) (20). It is probable that
chloroacetic acid (1), which is a vinylidene chloride
metabolite per se, lies on a major metabolic path-
way for vinylidene chloride, since it affords several
metabolites in common with vinylidene chloride
(20).
There is a strong supposition that detoxification
of chloroacetic acid (1) is effected through a gluta-
thione S-acyl transferase-catalyzed reaction pro-
cess and ensuing degradative sequence for the re-
sulting carboxymethylglutathione (n), and that this
represents the principal metabolic pathway for
chloroacetic acid and a major one for vinylidene
chloride. Thiodiglycollic acid is the ultimate detox-
ification product, and previous work (2) established
the biotransformation of S-(2-carboxymethyl) cys-
teine (g) into that substance. A feasible metabolic
pathway to thiodiglycollic acid from chloroacetic
acid and involving cysteine desulfhydrase is unac-
ceptable. In experiments (rats) with unlabeled
vinylidene chloride in which the cysteine-cystine
pools had been labeled with 14C, labeled thiodigly-
collic acid resulted, and a part of the C-skeleton of
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(20). Formation of a small amount of ['4C]thiodi-
glycollic acid (t) (and hence of the intermediate
[14C]thiodiglycollic acid) (s) is reconcilable with the
action of Michaelis's (21) unspecific 83-thionase,
which would lyse a small proportion ofthe prepon-
derating [14C]thiodiglycollic acid.
Moreover, Kolbe electrolysis (22) ofone molecu-
lar proportion of the ['4C]thiodiglycollic acid
metabolite from [1-14C] 1, 1-dichloroethylene or
[1-14C]chloroacetic acid gave one equivalent of
14C02(23), and this evidence is consistent with the
transformation of vinylidene chloride into
chloroacetic acid by a mechanism involving migra-
tion of one Cl atom and the loss of the other one
(20, 23). Hence, the metabolic pathway which was
tentatively proposed for the biotransformation of
vinylidene chloride into thiodiglycollic acid does in
fact operate in rats.
It is equivocal whether the very small amounts of
CO2 and urea are produced by the action ofepoxide
hydratase on 1,1-dichloroethylene oxide or by a
minor oxidative pathway for chloroacetic acid.
There is a strong supposition that the
N-acetyl-S-cysteinylacetyl derivative (p), which is
a metabolite of vinylidene chloride, but not of
chloroacetic acid, may be formed in fact from
1,l-dichloroethylene oxide through the agency of
glutathione S-epoxide transferase to afford
S-glutathione acetyl chloride (m) and its subsequent
reactions (20). This supposition is important, since
the reactivity displayed by 1,1-dichloroethylene
oxide appears to be relevant to the possible interac-
tion ofreactive vinylidene chloride metabolites with
mouse kidney DNA (Fig. 2), which is aprerequisite
of tumor initiation (24). Such interaction would be
analogous to that of vinyl chloride with rat-liver
DNA in vh'o, which forms imidazo derivatives with
some nucleoside residues (16). Further work is
in progress to investigate this hypothesis.
Comparative studies (25) provide clues of differ-
ences between rats and mice in the processing of
vinylidene chloride (Table 1). Thus, in mice, the
production of thiodiglycollic acid is considerably
reduced and the formation of the N-acetyl-S-
cysteinylacetyl metabolite is increased. The higher
/3-thionase activity in mice than in rats accounts for
the greater conversion of thiodiglycollic acid into
dithioglycollic acid v,ia thioglycollic acid in the
former species of animal. Yllner's (26) mice ex-
creted a proportion ofa dose ofchloroacetic acid as
unchanged starting acid. Thus, in mice, the
metabolic pathway from chloroacetic acid to
thiodiglycollic acid seems to be readily saturable,
possibly on account of an inadequacy in the reac-
tion catalysed by glutathione S-acyl transferase.
Under these circumstances, detoxification of
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FIGURE 2. Scheme suggesting the feasible interaction ofreactive
vinylidene chloride metabolites, I,1-dichloroethylene oxide
and chloroacetyl chloride, with adenosine and cytidine re-
spectively.
Table 1. Relative proportion of products from metabolism
of chloroacetic acid and vinylidene chloride
in rats and mice.
Yield of metabolites, %
Mice
Substrate Metabolite Rats Yllner BKJ-DEH
Chloroacetic Chloroacetic acid - 6-22 -
acid Thiodiglycollic acid 90 37 30-40
N-Acetyl-S-(2-carboxy-
methyl) cysteine 2 40 40
Vinylidene Chloroacetic acid 3
chloride Thiodiglycollic acid 37 3
Thioglycollic acid 3 5
Dithioglycollic acid 5 20
N-Acetyl-S-cysteinyl-
acetyl derivative 48 70
1, 1-dichloroethylene oxide by glutathione
S-epoxide transferase and the modification ofDNA
by 1,1-dichloroethylene oxide or chloroacetyl
chloride would be expected to be more significant in
mice than in rats. This diagnosis of species suscep-
tibility seems to accord with Maltoni's (24) discov-
ery of vinylidene chloride oncogenicity in (the kid-
neys of) mice.
Environmental Health PerspectivesVinylidene chloride emerges as an agent of low,
perhaps very low, oncogenic potential, which can
be damaging only in a special set of biological cir-
cumstances, which we have partially defined and on
which work is continuing.
The author is indebted to his colleagues Messrs. T. Green,
and B. K. Jones, Drs. A. G. Salmon and P. L. Batten, and Mr.
G. H. Walker for their invaluable contributions and help.
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